Document Detail


Short-term use of Goserelin depot in the treatment of dysfunctional uterine bleeding.
MedLine Citation:
PMID:  7554259     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PATIENTS: 60 premenopausal women (aged 36-50) with dysfunctional uterine bleeding, presenting simple endometrial hyperplasia.
RESULTS: after the treatment, spontaneous menstrual bleeding recurred in 57/60 patients, while 3/60 (5%) patients remained amenorrheal during the whole period of follow-up, showing a postmenopausal hormonal pattern. In the first post-therapy menstrual cycle all the 57 patients had a bleeding score < 100; patients relapsing during the second, third and fourth cycle were respectively 2/54 (3.7%), 5/48 (10.7%) and 17/38 (44.7%). The fourth post-therapy cycle was delayed 6-9 months after the last injection of Goserelin. Both the mean blood loss and the mean duration of bleeding were significantly reduced in all post-therapy cycles. Eleven patients were anaemic before therapy (Hb < 12 g%); Goserelin treatment resulted in a normalization of the hematological parameters. At the end of treatment a small area of hyperplasia persisted in only 4/60 patients (6.7%). Localised or diffused hyperplasia were found respectively in 5/54 (9.3%) and in 1/54 patients (1.9%) at three months, and in 5/48 (10.4%) and 4/48 (8.3%) at a six-month follow-up. Side effects were infrequent.
CONCLUSIONS: the long symptom-free period and the low incidence of side effects indicates Goserelin depot as a valuable medical treatment for dysfunctional uterine bleeding.
Authors:
N Colacurci; G De Placido; A Mollo; A Perino; E Cittadini
Related Documents :
16750259 - Prospective endometrial assessment of breast cancer patients treated with third generat...
11244659 - Thermal balloon endometrial ablation therapy induces a rise in uterine blood flow imped...
10924629 - Role of endometrial suppression on the frequency of intrauterine adhesions after resect...
14689749 - Initial experience with ovarian vein embolization for the treatment of chronic pelvic p...
17727849 - Spindle imaging: a marker for embryo development and implantation.
18295689 - Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas.
7609549 - Crinkling of epicardial defibrillator patches. a common and serious problem.
9753949 - Comparative study of three phacotrabeculectomy procedures through a single incision.
22536029 - Pharmacological enhancement of treatment for amblyopia.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Clinical and experimental obstetrics & gynecology     Volume:  22     ISSN:  0390-6663     ISO Abbreviation:  Clin Exp Obstet Gynecol     Publication Date:  1995  
Date Detail:
Created Date:  1995-10-26     Completed Date:  1995-10-26     Revised Date:  2011-01-11    
Medline Journal Info:
Nlm Unique ID:  7802110     Medline TA:  Clin Exp Obstet Gynecol     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  212-9     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, 2nd Medical School, Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Delayed-Action Preparations / therapeutic use
Dose-Response Relationship, Drug
Endometrial Hyperplasia / complications
Female
Goserelin / therapeutic use*
Humans
Menorrhagia / drug therapy*,  etiology
Metrorrhagia / drug therapy*,  etiology
Middle Aged
Premenopause
Chemical
Reg. No./Substance:
0/Delayed-Action Preparations; 65807-02-5/Goserelin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome. Beneficial and a...
Next Document:  Development of melanoma throughout two close pregnancies. Case report.